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Abstract
Background: Inositol 1,4,5-trisphosphate receptors (IP3R1, 2, and 3) are intracellular Ca
2+ release channels that regulate
various vital processes. Although the ryanodine receptor type 2, another type of intracellular Ca
2+ release channel, has been
shown to play a role in embryonic cardiomyocytes, the functions of the IP3Rs in cardiogenesis remain unclear.
Methodology/Principal Findings: We found that IP3R1
2/2-IP3R2
2/2 double-mutant mice died in utero with developmental
defects of the ventricular myocardium and atrioventricular (AV) canal of the heart by embryonic day (E) 11.5, even though
no cardiac defect was detectable in IP3R1
2/2 or IP3R2
2/2 single-mutant mice at this developmental stage. The double-
mutant phenotype resembled that of mice deficient for calcineurin/NFATc signaling, and NFATc was inactive in embryonic
hearts from the double knockout-mutant mice. The double mutation of IP3R1/R2 and pharmacologic inhibition of IP3Rs
mimicked the phenotype of the AV valve defect that result from the inhibition of calcineurin, and it could be rescued by
constitutively active calcineurin.
Conclusions/Significance: Our results suggest an essential role for IP3Rs in cardiogenesis in part through the regulation of
calcineurin-NFAT signaling.
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Introduction
Intracellular Ca
2+ signaling is crucial for cardiac functions [1].
Two types of Ca
2+ release channels on the sarcoplasmic/
endoplasmic reticulum (SR/ER) serve to regulate Ca
2+ release
from intracellular Ca
2+ stores: the ryanodine receptor (RyR) and
inositol 1,4,5-trisphosphate receptor (IP3R). RyR is mainly
required for physiologic excitation–contraction coupling in the
heart, whereas IP3R mediates Ca
2+ mobilization, in response to
IP3 produced by phospholipase C activation, not only in most non-
excitable cells but also in excitable cells including cardiomyocytes
[2]. There have been identified three subtype of IP3Rs (IP3R1,
IP3R2 and IP3R3), derived from three distinct genes in mammals
[3,4]. We previously generated mice that lacked IP3R1, IP3R2 and
IP3R3 by disrupting the corresponding gene within the first exon
[5,6], and reported the cerebellar phenotype of IP3R1
2/2 mice [5]
and the pancreatic phenotype of IP3R2
2/2-IP3R3
2/2 mice [6],
thereby demonstrating the specific and redundant roles of IP3Rs in
organ development and function. Regarding the heart, each
IP3R1, IP3R2, and IP3R3 single-mutant mouse showed normal
cardiogenesis, in contrast to the ryanodine receptor type 2 single-
mutant mouse, which showed embryonic lethality owing to
dysfunction of the SR in the embryonic cardiomyocyte [7].
Extracellular ligands binding to many receptors, including G-
protein coupled receptors and tyrosine-kinase coupled receptors,
lead to a transient release of Ca
2+ from ER/SR, through IP3Rs.
IP3-induced Ca
2+ release concurrently results in depletion of
intracellular Ca
2+ store, which triggers Ca
2+ release activated Ca
2+
(CRAC) channels [8]. Subsequent increase of cytosolic [Ca
2+]
through CRAC channels activates several Ca
2+- binding proteins,
including calcineurin, which in turn dephosphorylates and induces
the nuclear localization of the nuclear factor of activated T cells
(NFAT) transcription complexes [9]. During heart development,
NFATc1 is expressed in the endocardium of the AV canal that will
make up the endocardial cushion [10]. NFATc1 knockout
embryos show abnormal valvulogenesis [11,12], while NFATc2/
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demonstrate impaired endocardial cushion formation, thinning of
ventricular myocardium and dysregulation of vascular develop-
ment [10,13,14]. To determine the function of the intracellular
Ca
2+ signaling cascade via IP3Rs in the embryonic hearts, here we
generated and analyzed IP3R1 and IP3R2-deficient mice. Our
findings support an essential redundant role of IP3R1 and IP3R2
during cardiogenesis, possibly implicating the calcineurin/NFAT
signaling pathway.
Results
Overlapping Expression Patterns of IP3R1 and IP3R2 in
Embryonic Hearts
Firstly, we examined the normal pattern of expression of the
IP3Rs by RNA in situ hybridization. Consistent with a previous
report [15], expression of IP3R1 mRNA was detected at
embryonic day (E)8.5 in the heart, where it was enhanced in the
posterior part of the primitive heart, including the atrium (Fig. 1A).
IP3R1 mRNA expression extended to the ventricles through the
AV canal at E9.5–10.5 (Fig. 1A). In contrast, IP3R2 mRNA
expression was not detected at E8.5 but was detected at E9.5
throughout the heart, including the atrium, AV canal, and
ventricles (Fig. 1B). These expression signals were not detected by
sense riboprobes as a control (data not shown). Quantitative RT-
PCR using total RNA extracted from hearts at E8.5 to E16.0 and
western blot analysis of proteins at E9.5 and E12.5 indicated that
the IP3R1 and IP3R2 transcripts and proteins were expressed at
significant levels in the developing hearts (Fig. 1C and D),
consistent with the results of the RNA in situ hybridization
experiments. We performed an immunohistochemical analysis on
sections of the heart at E9.25, E9.75 and E10.5 to determine the
cell types in the embryonic heart that express the IP3R proteins. At
E9.25, IP3R1 was expressed in both endocardial cells and
myocardial cells, whereas IP3R2 was expressed dominantly in
endocardial cells (Fig. 1E). Co-expression of IP3R1 and IP3R2 was
observed in the endocardial cells of the AV canal (Fig. 1E). At
E9.75 to E10.5, the expression of IP3R2 expanded to the
myocardium and IP3R1 and IP3R2 were co-expressed not only
in the endocardial cells but also in the myocardial cells (Fig. 1E).
These expression signals with anti- IP3R1 and anti- IP3R2
antibodies were not detected in the sections of the IP3R1
2/2-
IP3R2
2/2 double-mutant embryos as a control (data not shown).
Cardiac Defects in IP3R1
2/2-IP3R2
2/2 Double-Mutant
Mice
To explore further the roles of the IP3Rs in cardiac
development, we delineated the cardiac phenotype of the IP3R
mutant mouse. IP3R1
2/2-IP3R2
2/2 double-mutant mice showed
embryonic lethality by E11.5 (see supporting information (SI)
Table S1) with heart defects, while either IP3R1
+/2-IP3R2
2/2 or
IP3R1
2/2-IP3R2
+/+ mouse developed normally through E11.5.
The IP3R1
2/2-IP3R2
2/2 double-mutant mice began to show
growth retardation at E9.5, although they appeared normal by
E9.25 and had regular cardiac contractions comparable to those of
wild-type. Detailed analysis of mouse hearts at E9.75 showed that
the ventricles of IP3R1
2/2-IP3R2
2/2 mice were more transparent
than those of IP3R1
+/2-IP3R2
2/2 mice, even though comparable
29 pairs of somites were developed, cardiac looping occurred
normally, and morphologic atria and ventricles were apparent in
both IP3R1
2/2-IP3R2
2/2 mice and IP3R1
+/2-IP3R2
2/2 mice
(Fig. 2A). Histological analysis revealed thin myocardial walls and
poor trabeculation in the ventricles of IP3R1
2/2-IP3R2
2/2 mice
at E9.75 (Fig. 2B). Together with the ventricular abnormalities,
hypocellularity in the cushion of AV canal was documented in the
IP3R1
2/2-IP3R2
2/2 hearts (Fig. 2B). Taken together with the
evidence of overlapping expression of IP3R1 and IP3R2 in the
developing ventricles and AV canal at E9.5 or later, these results
suggest that these two genes play redundant roles in cardiogenesis.
Although histologic abnormalities were noted, analysis using
electron microscopy found no structural defects in the subcellular
organelles, in the IP3R1
2/2-IP3R2
2/2 hearts at E9.5 (Fig. S1).
We performed a molecular analysis to investigate the association
between the IP3R1
2/2-IP3R2
2/2 double-mutant phenotype and
the differentiation of atrial and ventricular cardiomyocytes.
Nkx2.5, Mlc2a, and Mlc2v are the earliest markers of cardiomy-
ocyte differentiation in the atrium and ventricle during cardiogen-
esis [16,17,18]. These markers were expressed at normal levels in
IP3R1
2/2-IP3R2
2/2 hearts at E9.5 (Fig. S2). Markers for the right
ventricle (Hand2 [19]), left ventricle (Hand1 [19]) and both
ventricles (Hrt2 [20]) were also expressed normally in IP3R1
2/2-
IP3R2
2/2 hearts at E9.5 (Fig. S2). These results suggest that
cardiomyocyte differentiation and the specification of both
ventricles occur normally in IP3R1
2/2-IP3R2
2/2 hearts despite
poor formation of the ventricles.
In spite of the well-developed organs other than hearts in
IP3R1
2/2-IP3R2
2/2 embryos the early embryonic lethality of
IP3R1
2/2-IP3R2
2/2 mice and a previous report on the require-
ment for certain isotypes of phospholipase Cd that produce IP3 for
placentation [21,22] led us to investigate the possibility of placental
defects in IP3R1
2/2-IP3R2
2/2 mice. Histologic analysis revealed
that the embryonic vessels elongated and contact with the
maternal blood vessels in the IP3R1
2/2-IP3R2
+/2 or IP3R1
+/2
-IP3R2
2/2 placentas at E9.5. The area of the labyrinth layer,
which comprises a network of embryonic and maternal blood
vessels, was significantly smaller in the IP3R1
2/2-IP3R2
2/2
placenta than that in the IP3R1
+/2-IP3R2
2/2 placenta at E9.5
(Fig. S3).
Downregulated Cell Proliferation Activity in IP3R1
2/2-
IP3R2
2/2 Double-Mutant Ventricles
Next, we looked in the ventricles of IP3R1
2/2-IP3R2
2/2 mice
at E9.5 for cell proliferation markers using the anti-phospho-
histone H3 (PH3) antibody and 5-bromo-29-deoxy-uridine (BrdU),
and performed the TUNEL assay for apoptosis (Fig. 3 A and B).
The numbers of PH3-positive cells and BrdU-incorporated cells
were lower in the IP3R1
2/2-IP3R2
2/2 ventricular endocardium
and myocardium than in those of IP3R1
+/2-IP3R2
2/2 hearts,
whereas the numbers of proliferating cells in the pharyngeal arch
and the numbers of apoptotic signals detected by the TUNEL
assay were similar between IP3R1
2/2-IP3R2
2/2 and IP3R1
+/2-
IP3R2
2/2 embryos (Fig. 3A and B). These results indicate that the
redundant functions of IP3R1 and IP3R2 are essential for
ventricular cell proliferation. The IP3R1
2/2-IP3R2
2/2 mouse
phenotype is similar to that of mice lacking both Ca
2+-sensitive
transcription factors, NFATc3 and NFATc4, where the prolifer-
ation of the ventricular cells is considerably reduced [14].
IP3R1 and IP3R2 Redundantly Control Endocardial
Cushion Development through Calcineurin/NFATc
Signaling
Histological analyses of the developing hearts were performed
using alcian blue staining, which detects acidic mucosubstances, as
well as staining with biotinylated hyaluronan binding protein for
visualizing hyaluronan production (Fig. 4A). These analyses
revealed the absence of mesenchymal cells in the cushion of the
AV canal of IP3R1
2/2-IP3R2
2/2 mice at E9.5, whereas the
IP3 Receptors in Cardiogenesis
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2/2-IP3R2
2/2
hearts were comparable with those in the IP3R1
+/2-IP3R2
2/2
hearts. Expression of the transcription factor Tbx2 was also
normal in the AV canals of IP3R1
2/2-IP3R2
2/2 mice, which
suggests that specification and differentiation of the AV canal is
unaffected in the mutant mice (Fig. 4A). These findings led us to
hypothesize that IP3R1 and IP3R2 were required for the
epithelial-mesenchymal transformation (EMT) in the developing
AV cushion. To determine whether IP3R-mediated Ca
2+ signaling
could affect the process of EMT in the AV cushion, we performed
an in vitro EMT assay [23]. The E9.5 wild-type AV canal tissues
were explanted and treated with 2-aminoethoxydiphenyl borate
(2APB) onto a collagen gel, which is a non-selective membrane-
permeable inhibitor of IP3Rs and CRAC channels [24]. After 24 h
Figure 1. Both IP3R1 and IP3R2 are expressed in the embryonic heart. (A, B) Whole-mount in situ hybridization using IP3R1 (A) and IP3R2 (B)
antisense riboprobes at E8.5, E9.5, and E10.5. Whole-mount views (upper panels) and close-up views of the hearts (lower panels) are shown. Scale
bars: 1 mm (whole-mount views) and 0.2 mm (heart close-up views). (C) Quantitative RT-PCR of IP3R1 (black bars) and IP3R2 (gray bars) using total
RNA samples extracted from embryonic hearts at E8.5 to E16.0. Error bars indicate standard deviations. (D) Western blot of embryonic hearts with
anti-IP3R1 (18A10) and anti-IP3R2 (KM1083) antibodies. Lysates (10 mg) of hearts at E9.5 and E12.5 were analyzed. The protein contents of the heart
extracts were determined by the Bradford method. (E) The transverse sections of the wildtype embryos at E9.25, E9.75 and E10.5 were
immunostained with the anti-IP3R1 (upper panels) and anti-IP3R2 (lower panels) antibodies. Scale bars: 0.1 mm. a, atrium; avc, atrioventricular canal;
e, endocardium; h, head; ht, heart; m, myocardium; pa, pharyngeal arch; v, ventricle.
doi:10.1371/journal.pone.0012500.g001
Figure 2. Cardiac defects in IP3R1
2/2-IP3R2
2/2 mice. (A) The morphologies of the embryos and developing hearts of IP3R1
+/2-IP3R2
2/2 (upper
panels) and IP3R1
2/2-IP3R2
2/2 (lower panels) mice at E9.25 and at E9.75. Scale bars, 0.5 mm (whole-mount views) and 0.2 mm (heart close-up views).
(B) Hematoxylin and eosin-stained transverse sections of the anterior, middle and posterior segments of the hearts of IP3R1
+/2-IP3R2
2/2 (upper
panels) and IP3R1
2/2-IP3R2
2/2 (lower panels) mice at E9.75. The insets in the middle panels are higher-magnification images of the boxed areas. Scale
bars, 0.2 mm. a, atrium; avc, atrioventricular canal; fg, foregut; h, head; ht, heart; lv, left ventricle; oft, outflow tract; pa, pharyngeal arch; ph, pharynx;
rv, right ventricle.
doi:10.1371/journal.pone.0012500.g002
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significant decrease in the number of cells that transformed and
migrated into the collagen gel compared with control explants
treated with DMSO (Fig. 4B). Similarly, EMT was significantly
inhibited in the AV canal explants from IP3R1
2/2-IP3R2
2/2
embryo at E9.5 (Fig. 4B).
Of the several signaling pathways implicated in AV cushion and
myocardial development, we focused on calcineurin/NFAT
signaling because of the similarities noted between the phenotypes
of the IP3R1
2/2-IP3R2
2/2 mice and calcineurin- or NFATc-
deficient mice [10,13,14]. To determine whether IP3R1 and
IP3R2 regulate intracellular Ca
2+ signaling upstream of calci-
neurin/NFATc, we examined the cellular localization of NFATc1
in the AV canals of IP3R1
2/2-IP3R2
2/2 mice. Immunohisto-
chemical analysis revealed that NFATc1 failed to translocate into
the nuclei of the endocardial cells in the AV canals of IP3R1
2/2
-IP3R2
2/2 mice at E9.5, and that the expression of NFATc1 was
downregulated by E10.5 (Fig. 4C). Nuclear translocation of
NFATc1 appeared normal at E9.25 but was inhibited from E9.5
(Fig. S4). Next, we examined the activation of NFATc4 by western
blot analysis using the lysates from IP3R1
2/2-IP3R2
2/2 hearts at
9.75. The quantity of the dephosphorylated form of NFATc4 was
decreased in the IP3R1
2/2-IP3R2
2/2 heart compared to the
IP3R1
+/2-IP3R2
2/2 heart (Fig. 4D). These observations are
reminiscent of those made for calcineurin B*/* mice, in which
the activation of calcineurin B is disrupted [13]. To provide
further evidence for the possible interaction between IP3Rs and
calcineurin/NFATc signaling, we tested whether constitutively
Figure 3. IP3R1 and IP3R2 redundantly regulate cardiomyocyte proliferation in the developing ventricles. (A) Transverse sections of
E9.5 IP3R1
+/2-IP3R2
2/2 (upper panels) and IP3R1
2/2-IP3R2
2/2 (lower panels) embryos that were immunostained with the anti-phospho-histone H3
(PH3) antibody, immunostained with the anti-BrdU antibody after injection of BrdU, and subjected to the TUNEL assay. The green signals (white
arrowheads) in the left panels, brown signals in the middle panels (arrows) and yellow signals (white arrowheads) in the right panels indicate the
nuclei of the PH3-, BrdU-, and TUNEL-positive cells, respectively. Scale bars, 0.2 mm. a, atrium; v, ventricle. (B) The left and middle graphs show the
percentages of proliferating cells in the whole ventricles, the endocardium and myocardium of the ventricles, and the pharyngeal arches of IP3R1
2/2-
IP3R2
2/2 mutants (gray bars), compared with those of IP3R1
+/2-IP3R2
2/2 controls (black bars) (*P,0.05, n=3). The right graph shows the number of
apoptotic cells (P=0.45, n=7). Error bars indicate standard deviations.
doi:10.1371/journal.pone.0012500.g003
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2/2-
IP3R2
2/2. Infection of cytomegalovirus-associated constitutively
active calcineurin, which can be activated independently of Ca
2+
increase by deletion of its calmodulin binding domain and
autoinhibitory domain [25], significantly restored the EMT
activity in IP3R1
2/2-IP3R2
2/2 AV explants (Fig. 4E). Taken
together, our results indicate that IP3R1 and IP3R2, at least in
part, redundantly activate and maintain calcineurin/NFATc
signaling.
To investigate further whether IP3R-mediated Ca
2+ signaling is
required for AV cushion development, we utilized a relatively
simple model of heart development in zebrafish treated with an
inhibitor of IP3R (Fig. 5A). As described previously [10], treatment
with the calcineurin inhibitors cyclosporine A (CsA) or FK506
between 24 h and 33 h postfertilization (hpf) affects AV cushion
development and heart valve formation in zebrafish. Intriguingly,
treatment with 2APB between 24 hpf and 33 hpf disrupted AV
cushion development in zebrafish (Fig. 5A) in a dose-dependent
fashion (Fig. 5B). This results in a massive regurgitation of the AV
valve and heart failure with pericardial effusion reminiscent of
treatment with CsA (Fig. 5A and Video S1). Although myocardial
development appeared normal by staining of the sarcomeric
protein MF20, disruption of AV canal cushion development, and
possibly decreased myocardial function, was common in CsA-
treated and 2APB-treated zebrafish (Fig. 5A and B). These data
further support that IP3R-mediated signaling is essential for AV
cushion development, possibly implicating the calcineurin/NFAT
signaling across species.
Discussion
In the present study, we used a series of molecular, pha-
rmacologic and genetic manipulations in mice and zebrafish to
demonstrate that IP3Rs are involved in the local control of Ca
2+
that is necessary to activate the calcineurin-NFATc signaling
pathway required for cardiogenesis. To date, it has been shown
that calcineurin/NFATc signaling has an important role for AV
cushion formation, valvulogenesis, and cardiomyocyte develop-
ment [10,11,12,14], however, the process by which this signaling is
activated by Ca
2+ has not been elucidated. In Xenopus embryos,
NFAT is a downstream effecter of the IP3-Ca
2+ signal during
dorsoventral axis formation [26]. In mammals, IP3Rs act upstream
of calcineurin/NFAT signaling in T lymphocytes in vitro [27]. In
this study, we have indentified that IP3R1 and IP3R2 may exist, at
least in part, upstream of calcineurin/NFATc signaling during
heart development. Our data provide new insights into the way
how Ca
2+ signals regulate Ca
2+-binding molecules essential for
cardiogenesis, such as the Ca
2+ dependent phosphatase, calci-
neurin.
Here, we have shown several lines of findings that support that
the IP3R-mediated Ca
2+ signaling may be implicated in the
calcineurin/NFATc signaling pathway although it is difficult to
clarify whether IP3Rs may directly activate calcineurin during
cardiogenesis. We showed that NFATc1 and NFATc4 were not
activated in IP3R1
2/2-IP3R2
2/2 mice at E9.5 (Fig. 4C and D),
and that the expression of NFATc1 was downregulated by E10.5
(Fig. 4C), using immunohistological and biochemical experiments.
Moreover, we showed that the disturbance of endocardial cushion
development in IP3R1
2/2-IP3R2
2/2 embryos could be rescued by
addition of constitutively active calcineurin (Fig. 4E). These data
indicate that IP3R1 and IP3R2 may, directly or indirectly, function
redundantly in the activation of calcineurin/NFAT signaling.
Vascular endothelial growth factor (VEGF), inducing NFATc1
nuclear translocation, markedly increases the proliferation of valve
endothelial cells in vitro [28]. The VEGF receptor tyrosine kinase
activating phospholipase Cc-I P 3 signal triggers intracellular Ca
2+
increase [29], suggesting that VEGF might be a candidate of
extracellular signals upstream of IP3Rs-NFATc1 activation in the
endocardium. Failure of nuclear translocation and downregulation
of NFATc1 is probably due to disruption of some of the following
positive feedback mechanisms: 1) NFATc1-binding to the
promoter/enhancer of the NFATc gene [30]; 2) activation of
calcineurin transcription by NFATc [31]; and 3) induction of the
IP3R1 gene as previously documented in neurons [32].
We also showed that the phenotype of IP3R1
2/2-IP3R2
2/2
embryos involved that of the NFATc2/3/4 knockout mice
[10,13,14] and was much more severe than that of the NFATc1
null mice [11,12]. Therefore, it is likely that IP3R-mediated Ca
2+
signaling during cardiogenesis regulates NFATc family members
in addition to NFATc1 as well as unknown downstream targets
other than the calcineurin/NFATc signaling pathway. It is also
unclear whether endocardial or myocardial cells are primarily
affected in the IP3R1
2/2-IP3R2
2/2 embryos. In characterizing
the role of this pathway in heart development, our study revealed
the co-expression and involvement of IP3R1 and IP3R2 in the
development of both endocardial and myocardial cells. Unequiv-
ocal answer about the functions of IP3R1 and IP3R2 for cardiac
development awaits further study of cell-specific conditional
knockout mice.
Although our experiments in AV explants and in zebrafish using
2APB support our hypothesis led by our experiments using
IP3R1
2/2-IP3R2
2/2 mice, there is a limitation for using 2APB.
Figure 4. IP3Rs are essential for EMT through calcineurin activity during endocardial cushion development in mice. (A) Hematoxylin
and eosin staining, alcian blue staining, staining with biotinylated hyaluronan binding protein and whole-mount in situ hybridization for a marker of
the atrioventricular (AV) myocardium (Tbx2) of IP3R1
+/2-IP3R2
2/2 (upper panels) and IP3R1
2/2-IP3R2
2/2 (lower panels) embryos at E9.5. Mesenchymal
cells are absent from the IP3R1
2/2-IP3R2
2/2 AV cushion (arrowheads), whereas the staining levels for alcian blue (blue signals), hyaluronan (green
signals) and Tbx2 (purple signals) are not altered. Scale bars, 0.1 mm. (B) In vitro EMT assay using the endocardial cushion from the AV canal. The left
panels show that treatment of wild-type (WT) cushion explants with the IP3R inhibitor 2APB inhibits the outgrowth of spindle-shaped cells as
compared with the control treatment (DMSO). The right panels show the IP3R1
+/2-IP3R2
2/2 and the IP3R1
2/2-IP3R2
2/2 AV cushion explants. The
higher magnification views of the explants are shown besides. The spindle-shaped cells migrating into collagen gel are indicated with yellow
arrowheads. The number of the spindle-shaped migrating cells is significantly lower in the culture that contains 2APB (left graph) and in the culture
from the IP3R1
2/2-IP3R2
2/2 AV cushion (right graph) (*P,0.05, n=3). Error bars indicate standard deviations. (C) Transverse sections at the level of
the AV canal stained with the anti-NFATc1 antibody and TOPRO3 show impairment of translocation of NFATc1 into nuclei at E9.5. The expression
level of NFATc1 is decreased at E10.5 in IP3R1
2/2-IP3R2
2/2 hearts. Scale bars, 0.05 mm. Arrowheads indicate the AV canal and higher-magnification
images of the boxed area. (D) Western blot analysis with anti-NFATc4 antibody using heart lysates of the wildtype and the IP3R1
2/2-IP3R2
2/2 embryos
at E9.75. Blotting with anti-GAPDH antibody on each lane was used as a loading control. The inactive form of NFATc4 (p-NFATc4) remained and active
form (NFATc4) was reduced in IP3R1
2/2-IP3R2
2/2 hearts compared to IP3R1
+/2-IP3R2
2/2 hearts. (E) The structures of the wildtype calcineurin (WT CN)
and the constitutively active form of calcineurin (CA CN) cDNA are shown. Infection with CA CN cDNA resulted in significant increase in the number of
the spindle-shaped and a smooth muscle actin (aSMA)-positive cells (yellow arrowheads) in the culture of IP3R1
2/2-IP3R2
2/2 AV cushion explants
(*P,0.05, n=4). a, atrium; e, endocardium; lv, left ventricle; m, myocardium, rv, right ventricle; v, ventricle.
doi:10.1371/journal.pone.0012500.g004
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channel inhibitor in addition to having an inhibitory effects on not
only IP3R1 and IP3R2, but also other subtype of IP3R [33].
Unfortunately, there is no selective IP3R inhibitor presently
available. The observed defect in AV explants and in zebrafish
with 2APB should include the possible effects of 2APB on CRAC
channel activity, although AV explants from IP3R1
2/2-IP3R2
2/2
mice showed similar defect. There also is a limitation to determine
the cause of death in the IP3R1
2/2-IP3R2
2/2 mice in this study.
The placental defect, in conjunction with the cardiac defect, are
likely to account for embryonic lethality in these mice, however,
we could neither correctly estimate impact of each defect nor rule
out defects of other organs. Further strategy for inactivation of the
specific IP3R in specific tissues and organs would be required to
overcome these limitations appeared in this study.
The DSCR1/MCIP1 gene encoding a calcineurin inhibitor is
located on human chromosome 21 and a reduction of NFATc
activity is associated with a 1.5-fold increase in gene dosage of
DSCR1 and many of the features of Down (Trisomy 21)
syndrome, including AV canal defects [34]. The balance between
Ca
2+-sensitive positive (e.g., IP3Rs) and negative (e.g., DSCR1)
regulation of NFATc may be crucial for organogenesis. Under-
standing the novel roles of IP3R-mediated Ca
2+ signaling opens
new avenues of research regarding the molecular embryology of
the heart, which may lead to regenerative interventions for
patients with congenital heart defects.
Materials and Methods
Animals
IP3R1/2 double-knockout mice were generated by intercrossing
IP3R1
+/2-IP3R2
2/2 paired mice [5,6]. Genomic DNA samples
prepared from tail biopsies or yolk sacs were subjected to PCR for
genotyping, as described previously [5,6]. Zebrafish (Danio rerio)
embryos were obtained from the natural spawning of a wild-type
ABK line. CsA (50 mg/mL) or 2APB (5 mM) was added between
24 hpf and 33 hpf, and the zebrafish were harvested at 72 hpf for
analysis [10]. All experimental procedures and protocols were
approved by the animal care and use committees of Keio
University (the approval number 09122-(3)) and conformed to
the National Institutes of Health Guidelines for the Care and Use of
Laboratory Animals.
Western Blotting, Quantitative RT-PCR, Whole-Mount
in situ Hybridization, and Immunohistochemistry
Total heart extracts (10 mg) from E9.5 and E12.5 mice were
subjected to 5% SDS-PAGE and analyzed by western blotting
with anti-IP3R1 (18A10) [35] and anti-IP3R2 (KM1083) antibod-
ies [36]. For quantitative RT-PCR analysis of IP3R1 and IP3R2
expression, cDNAs were synthesized using the High Capacity
cDNA Archive kit (Applied Biosystems) from total RNA samples
extracted from embryonic hearts or placentas using the RNeasy kit
(Qiagen). These cDNAs were used as templates in a TaqMan
Real-Time PCR with the ABI 7500 Real-Time PCR system
(Applied Biosystems). The data are normalized to the levels
obtained for GAPDH. The TaqMan probes used for IP3R1 and
IP3R2 were Mm00439917_m1 and Mm00444937_m1 (Applied
Biosystems), respectively. The whole-mount RNA in situ hybrid-
ization and immunohistochemistry were performed as previously
described [13,37]. The antibodies used for immunohistochemistry
on the sections were: mouse anti-NFATc1 (7A6) monoclonal
antibody (1:100; Santa Cruz Biotechnology), anti-phospho-histone
H3 (Ser10) antibody (1:100; Upstate), anti-BrdU antibody (1:75;
Becton Dickinson), anti-NFATc4 (H-74) antibody (1:250; Santa
Cruz Biotechnology) and anti-a smooth muscle actin (1A4)
antibody (1:400; Sigma).
EMT Assay
The EMT assay was performed as reported previously [23].
Endocardial cushions from the atrioventricular canal were
explanted onto rat-tail collagen gel (BD Biosciences). After 24 h
of incubation with 2APB, which is a non-selective inhibitor of
IP3Rs [24], or with DMSO as a control, the total number of
mesenchymal cells in each dish was counted. AV canal explants
were infected using inactivated adenovirus harboring the gene
encoding cytomegalovirus-driven constitutively active calcineurin
[25] (Adeno-X ViraTrak Expression System 2, Clontech). After
overnight incubation to allow attachment, each explant was
incubated with 6.4610
4 viral particles in culture medium.
Figure 5. Inhibition of IP3Rs and calcineurin results in a
common developmental defect in zebrafish hearts. (A) The left
panels show the gross abnormalities in the hearts of zebrafish treated
with DMSO, CsA (calcineurin inhibitor), and 2APB (IP3R inhibitor).
Atrioventricular regurgitation is induced by the addition of CsA and
2APB, resulting in heart failure with pericardial swelling (yellow
arrowheads). The middle panels show the histologic abnormalities
including a decrease in the number of cushion cells in the
atrioventricular valves (arrowheads). The right panels show the
expression of sarcomeric protein MF20 in zebrafish hearts that did
not alter with CsA- or 2APB-treatment. (B) The significant increase in the
number of zebrafish with pericardial swelling following the addition of
CsA, FK506, or 2APB, is indicated in the graph (*P,0.05, n=3). Error
bars indicate standard deviations. a, atrium; ey, eye; ht, heart; v,
ventricle; y, yolk.
doi:10.1371/journal.pone.0012500.g005
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days and then assessed as indicated.
Statistical Analysis
All data are expressed as mean 6 s.d. (n$3). Statistical analysis
was performed using the Student’s t-test. The results shown are
representative of more than three independent experiments.
Supporting Information
Materials and Methods S1
Found at: doi:10.1371/journal.pone.0012500.s001 (0.03 MB
DOC)
Table S1 Genotype Distributions of Embryos from IP3R1
+/2-
IP3R2
2/2 Intercrosses.
Found at: doi:10.1371/journal.pone.0012500.s002 (0.03 MB
DOC)
Figure S1 The ultrastructures of the subcellular organelles of the
IP3R1
2/2-IP3R2
2/2 mice are comparable with those of the
IP3R1
+/2-IP3R2
2/2 mice. Scale bars, 1 mm. g, golgi; m,
mitochondrion; mf, myofilament; n, nucleus; rer, rough endoplas-
mic reticulum; sr, sarcoplasmic reticulum.
Found at: doi:10.1371/journal.pone.0012500.s003 (1.74 MB TIF)
Figure S2 Expression of site-specific markers in embryonic
hearts. Whole-mount in situ hybridization images of the left- or
right-side of the hearts of E9.5 IP3R1
+/2-IP3R2
2/- (upper panels)
and IP3R1
2/2-IP3R2
2/2 (lower panels) embryos. The expression
patterns of Nkx2.5, MLC2a, and MLC2v (earliest markers of the
embryonic heart), and of Hand2, Hand1 and Hrt2 (markers of the
right, left, and both ventricles, respectively) are shown. Scale bars,
0.2 mm. a, atrium; lv, left ventricle; oft, outflow tract; pa,
pharyngeal arch; rv, right ventricle.
Found at: doi:10.1371/journal.pone.0012500.s004 (5.26 MB TIF)
Figure S3 Cross-sections of E9.5 placentas from IP3R1
2/2-
IP3R2
+/2 (upper panels), IP3R1
+/2-IP3R2
2/2 (middle panels) and
IP3R1
2/2-IP3R2
2/2 (lower panels) mutant mice. The widths of
the labyrinth area indicated in parentheses. Higher-magnification
images of the boxed areas are shown in the right panels. Scale
bars, 0.5 mm. The graph shows quantification of the labyrinth
areas of the IP3R1
+/2-IP3R2
2/2 and IP3R1
2/2-IP3R2
2/2
placentas at E9.5. The area of the IP3R1
2/2-IP3R2
2/2 labyrinth
is significantly lower (*P,0.05, n=3). Error bars indicate standard
deviations. ev, embryonic vessel; mv, maternal vessel.
Found at: doi:10.1371/journal.pone.0012500.s005 (5.68 MB TIF)
Figure S4 The percentages of cells with nuclear translocation of
NFATc1 in the IP3R1
2/2-IP3R2
2/2 hearts (white bars) are
significantly lower than those in the IP3R1
+/2-IP3R2
2/2 hearts
(black bars) at E9.5 to E10.0 (*P,0.01, n=3). Error bars indicate
standard deviations.
Found at: doi:10.1371/journal.pone.0012500.s006 (2.97 MB TIF)
Video S1 Atrioventricular regurgitation in the zebrafish hearts
treated with DMSO (top), calcineurin inhibitor, cyclosporine A,
(middle) and IP3R inhibitor, 2APB, (bottom).
Found at: doi:10.1371/journal.pone.0012500.s007 (0.32 MB
MOV)
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